SBS Stratec SE

XETRA · DE · Healthcare · Medical Devices · stratec.com

21.50EUR-0.92%Mkt Cap: 284.08M $P/E: —Today

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures auto…

Industry Peers

Medical Devices

Screen all

ABT

Abbott Laboratories Common Stock

$169.83BUSDP/E 31.6

MDT

Medtronic plc. Ordinary Shares

$110.49BUSDP/E 21.2

SYK

Stryker Corporation Common Stock

$105.65BUSDP/E 28.5

BSX

Boston Scientific Corporation Common Stock

$61.74BUSDP/E 17.2

Edwards Lifesciences Corporation Common Stock

$49.03BUSDP/E 50.7

SHL

Siemens Healthineers AG

$46.06BUSDP/E 19.2

DXCM

DexCom, Inc. - Common Stock

$32.21BUSDP/E 33.7

GEHC

GE HealthCare Technologies Inc. - Common Stock

$29.24BUSDP/E 14.8

PHG

Koninklijke Philips N.V. NY Registry Shares

$23.38BUSDP/E 18.5

PHIA

Koninklijke Philips N.V.

$22.58BUSDP/E 18.5

STE

STERIS plc (Ireland) Ordinary Shares

Zimmer Biomet Holdings, Inc. Common Stock

$16.84BUSDP/E 21.4

PEN

Penumbra, Inc. Common Stock

$12.51BUSDP/E 77.8

TXG

10x Genomics, Inc. - Common Stock

$12.18BUSD

SNN

Smith & Nephew SNATS, Inc. Common Stock

$11.06BUSDP/E 18.0

GMED

Globus Medical, Inc. Class A Common Stock

Bio-Rad Laboratories, Inc. Class A Common Stock

$9.88BUSDP/E 45.0

GKOS

Glaukos Corporation Common Stock

$9.66BUSD

Key Statistics

Company

Market Cap284.08M USD

Enterprise Value391.82M USD

Revenue (TTM)266.10M USD

Gross Profit69.80M USD

Net Income (TTM)-263.04K USD

Revenue/Share20.14 EUR

Last Price21.50 EUR

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.4K

CountryDE

SectorHealthcare

IndustryMedical Devices

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)12.48

PEG0.98

EV/EBITDA12.73

EV/Revenue1.47

P/S1.08

P/B1.11

EPS (TTM)-0.03

EPS (Forward)1.74

52W Range

16.3031% of range33.10

52W High33.10 EUR

52W Low16.30 EUR

Profitability

Gross Margin25.60%

Oper. Margin9.43%

EBITDA Margin11.57%

Profit Margin-0.10%

ROE-0.10%

ROA-0.06%

Growth

Revenue Growth1.50%

Earnings Growth277.80%

Cash Flow & Leverage

Operating CF-470.65K USD

CapEx (TTM)17.64M USD

FCF Margin5.33%

FCF Yield4.99%

Net Debt105.09M USD

Net Debt/EBITDA3.41

Balance Sheet

Debt/Equity0.56

Current Ratio4.23

Quick Ratio1.75

Book Value/Sh19.61 EUR

Cash/Share1.57 EUR

Dividends

Fwd Div Rate0.60 EUR

Trail. Div Rate0.60 EUR

Div. Yield2.77%

5Y Avg Yield1.49%

Payout Ratio47.24%

Ex-Div DateJun 24, 2026

Pay Date—

Splits

Last Split2.994:1

Split DateJul 31, 2006

Analyst Consensus

Rating—

Target (Mean)25.60 EUR

Upside (mean)+19.1%

Target Range21.00 EUR – 37.00 EUR

21.00+19.1% to mean37.00

# Analysts5

Ownership

Shares Out.12.16M

Float11.54M

Insiders61.12%

Institutions34.11%

Technical

SMA 5022.47 (-4.3%)

SMA 20020.06 (+7.2%)

Beta0.84

S&P 52W Chg14.58%

Avg Vol (30d)12.22K

Avg Vol (10d)13.71K

Technical Indicators

RSI (14)37.6

MACD-0.2785

MACD Signal0.0943

MACD Hist.-0.3728

BB Upper26.02 EUR

BB Middle23.52 EUR

BB Lower21.02 EUR

BB Width21.25%

ATR (14)0.8996 EUR

Vol Ratio (20d)0.50x